Viking Therapeutics Inc.
VKTX | NASDAQ
$30.11
+$1.12 (+3.86%)
At close: Sep 21, 2026, 4:00 PM ET
$32
+$1.89 (+6.28%)
Pre-market:
Sep 22, 2026, 4:21 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 208K | 208K | 208K | 114K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 71K | 71K | 71K |
Gross Profit | -208K | -208K | -208K | -114K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -71K | -71K | -71K |
Operating Income | -560.02M | -502M | -393.34M | -274.84M | -212.84M | -172.32M | -150.92M | -133.97M | -124.68M | -114.36M | -100.83M | -91.83M | -80.76M | -74.65M | -70.36M | -62.58M | -59.79M | -57.7M | -55.68M | -54.44M | -50.88M | -45.94M |
Interest Income | 25.15M | 29.64M | 33.7M | 37.51M | 41.27M | 44.06M | 40.94M | 34.8M | 28M | 20.73M | 15.02M | 11.05M | 6.76M | 2.47M | 1.59M | 1.02M | 691K | 619K | 704K | 858K | 1.31M | 2.17M |
Pretax Income | -534.8M | -472.34M | -359.64M | -237.39M | -171.55M | -128.24M | -109.96M | -99.15M | -96.75M | -93.72M | -85.9M | -80.85M | -74.09M | -72.3M | -68.87M | -61.66M | -59.13M | -57.08M | -54.99M | -53.58M | -49.63M | -43.82M |
Net Income | -534.8M | -472.34M | -359.64M | -237.39M | -171.55M | -128.24M | -109.96M | -99.15M | -96.75M | -93.72M | -85.9M | -80.85M | -74.09M | -72.3M | -68.87M | -61.66M | -59.13M | -57.08M | -54.99M | -53.58M | -49.63M | -43.82M |
Selling & General & Admin | 50.71M | 48.28M | 48.39M | 52.36M | 57.52M | 53.39M | 49.28M | 42.81M | 37.92M | 37.46M | 37.02M | 32.34M | 27.69M | 21.96M | 16.12M | 14.68M | 13.05M | 11.7M | 10.7M | 10.18M | 10.3M | 10.39M |
Research & Development | 509.32M | 453.72M | 344.96M | 222.48M | 155.32M | 118.93M | 101.64M | 91.16M | 86.75M | 76.9M | 63.81M | 59.48M | 53.06M | 52.69M | 54.23M | 47.9M | 46.74M | 46M | 44.98M | 44.18M | 40.5M | 35.48M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 560.02M | 502M | 393.34M | 274.84M | 212.84M | 172.32M | 150.92M | 133.97M | 124.68M | 114.36M | 100.83M | 91.83M | 80.76M | 74.65M | 70.36M | 62.58M | 59.79M | 57.7M | 55.68M | 54.37M | 50.81M | 45.87M |
Interest Expense | 8K | 32K | 56K | 80K | 96K | 90K | 94K | 96K | 74K | 88K | 88K | 70K | 95K | 75K | 47K | 51K | 24K | 33K | 54K | 63K | 83K | 82K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 560.02M | 502M | 393.34M | 274.84M | 212.84M | 172.32M | 150.92M | 133.97M | 124.68M | 114.36M | 100.83M | 91.83M | 80.76M | 74.65M | 70.36M | 62.58M | 59.79M | 57.7M | 55.68M | 54.44M | 50.88M | 45.94M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 115.92M | 115.57M | 114.01M | 112.32M | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.51M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M | 74.78M |
Shares Outstanding (Diluted) | 115.92M | 115.57M | 114.01M | 112.32M | 112.13M | 112.07M | 111.34M | 110.91M | 110.39M | 103.46M | 100.11M | 99.85M | 99.01M | 78.35M | 76.59M | 76.51M | 77.03M | 77.41M | 76.91M | 78.01M | 77.9M | 74.78M |
EPS (Basic) | -4.66 | -4.14 | -3.18 | -2.12 | -1.53 | -1.15 | -1 | -0.93 | -0.94 | -0.93 | -0.91 | -0.91 | -0.88 | -0.92 | -0.89 | -0.80 | -0.77 | -0.74 | -0.72 | -0.71 | -0.67 | -0.60 |
EPS (Diluted) | -4.66 | -4.14 | -3.18 | -2.12 | -1.53 | -1.15 | -1 | -0.93 | -0.94 | -0.93 | -0.91 | -0.91 | -0.88 | -0.92 | -0.89 | -0.80 | -0.77 | -0.74 | -0.72 | -0.71 | -0.67 | -0.60 |
EBITDA | -534.42M | -471.98M | -359.15M | -236.87M | -171.03M | -127.76M | -109.52M | -98.75M | -96.38M | -93.34M | -85.52M | -80.49M | -73.63M | -71.93M | -68.53M | -61.32M | -58.88M | -56.75M | -54.88M | -53.81M | -50.41M | -44.61M |
EBIT | -534.79M | -472.3M | -359.58M | -237.31M | -171.45M | -128.15M | -109.87M | -99.06M | -96.67M | -93.63M | -85.81M | -80.78M | -73.99M | -72.22M | -68.82M | -61.61M | -59.11M | -57.05M | -55.18M | -54.1M | -50.7M | -44.89M |
Depreciation & Amortization | 365K | 320K | 431K | 447K | 420K | 383K | 346K | 310K | 296K | 294K | 292K | 290K | 359K | 286K | 291K | 295K | 228K | 301K | 296K | 291K | 286K | 281K |
Add to Watchlist
Select watchlists to add or remove VKTX